Oral eplerenone for the management of chronic central serous chorioretinopathy

Oral eplerenone for the management of chronic central serous chorioretinopathy

AIM: To examine eplerenone (Inspra, Pfizer), a mineralocorticoid receptor antagonist, as a treatment option for chronic central serous chorioretinopathy (CSCR). METHODS: A retrospective consecutive case series was conducted for patients receiving oral eplerenone for chronic CSCR. At baseline and e...

Full description

Bibliographic Details
Main Authors: Rishi P Singh, Jonathan E Sears, Rumneek Bedi, Andrew P Schachat, Justis P Ehlers, Peter K Kaiser
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2015-04-01
Series:International Journal of Ophthalmology
Subjects:
central serous chorioretinopathy
central serous retinopathy
eplerenone
subretinal fluid
Online Access:http://www.ijo.cn/en_publish/2015/2/20150217.pdf

Internet

http://www.ijo.cn/en_publish/2015/2/20150217.pdf

Similar Items